Tech Innovations Boost Medical Device Cleaning Market Growth

According to the latest market research study published by P&S Intelligence, the global medical device cleaning market is projected to generate an estimated revenue of USD 2,735.2 million in 2024, with expectations to reach USD 3,773.2million by 2030, reflecting a compound annual growth rate (CAGR) of 5.5% during the forecast period.

This growth is primarily driven by increasing awareness among healthcare professionals and patients regarding the importance of properly cleaned medical devices. Factors such as the rising prevalence of chronic diseases, a surge in the number of surgical procedures, and a growing elderly population further contribute to the market's expansion. Additionally, the COVID-19 pandemic has heightened the focus on infection control practices, emphasizing the critical role of medical device cleaning in preventing healthcare-associated infections (HAIs).

To Learn More About This Report

Key Insights

Segmentation Analysis

By Application: The market is categorized into surgical instruments, endoscopes, ultrasound probes, and dental instruments. Among these, surgical instruments hold a significant share due to the high volume of surgeries performed globally, necessitating stringent cleaning protocols.

By Device Type: Devices are classified as critical, semi-critical, and non-critical, based on their contact with sterile body areas or mucous membranes. Critical devices, which come into contact with sterile tissues, require rigorous cleaning and sterilization, thereby driving the demand in this segment.

By Process: The cleaning processes include presoaking/precleaning, disinfection, automatic cleaning, and manual cleaning. The disinfection segment is anticipated to witness substantial growth due to its effectiveness in eliminating pathogens from medical devices.

By Product: The market offers detergents and chemicals specifically designed for cleaning medical devices. Detergents are widely used owing to their efficacy in removing organic and inorganic residues without damaging the instruments.

Regional and Geographical Trends:

North America: This region leads the market, attributed to advanced healthcare infrastructure, stringent regulations, and high awareness regarding infection control practices.

Asia-Pacific: Forecasted to be the fastest-growing region, driven by increasing healthcare investments, rising medical tourism, and a growing focus on improving healthcare facilities.

Technological Advancements Shaping the Market:​

The development of automated cleaning technologies enhances efficiency and consistency in cleaning processes, reducing the risk of human error.

Innovations in eco-friendly and non-toxic cleaning agents address environmental concerns and ensure patient safety.

Competitive Dynamics, Major Players, and Emerging Opportunities:

The market is fragmented, with key players focusing on product innovation and strategic collaborations to strengthen their market position.

Emerging opportunities lie in developing cost-effective cleaning solutions tailored for emerging economies, where healthcare facilities are expanding rapidly.

Companies investing in research and development to create advanced cleaning technologies and eco-friendly products are likely to gain a competitive edge.

In summary, the medical device cleaning market is poised for steady growth, driven by heightened awareness of infection control, technological advancements, and expanding healthcare infrastructures globally. Stakeholders focusing on innovation and strategic partnerships are well-positioned to capitalize on emerging opportunities in this evolving landscape.

Read More

How Does Prevalence of Pancreatic Cancer Expand Endoscopic Retrograde Cholangiopancreatography Market?

In 2021, the endoscopic retrograde cholangiopancreatography market was worth around USD 1,270.9 million, and it is projected to advance at an 8.1% CAGR from 2021 to 2030, hitting USD 2,557.7 million by 2030, according to P&S Intelligence. This growth can be credited to the growth in the occurrence of pancreatic cancer and a paradigm move toward minimally invasive procedures.

Get the sample pages of this report: https://bit.ly/3KFz6Lg

In 2021, Endotherapy devices and endoscopes together had approximately 70% share. This can be credited to the surge in the need for ERCP devices attached to the high occurrence of choledocholithiasis, pancreatitis, pancreatitis, and pancreatic cancer. According to the American Health Organization, over60,000 individuals are projected to have gone through pancreatic cancer in 2022, and around 50,000 individuals will expire from it, in the U.S.

The North American endoscopic retrograde cholangiopancreatography industry, generated the largest revenue share of approximately USD 471.4 million, in 2021. Approximately 3% of demises in the U.S. region happen because of pancreatic cancer each year.

Furthermore, the increasing drinking of alcohol is leading to numerous illnesses including pancreatic adenocarcinoma and pancreatic neuroendocrine tumor. Such reasons are ensuing in the high utilization of ERCP procedures in the continent. Furthermore, over 20% of the Canadian populace suffers from bile duct illness, which is further boosting the growth of the market.

Moreover, the sanction of numerous ERCP devices by the FDA in the continent also strengthens industry growth. For example, in July 2020, Ambu Inc. got the FDA sanction for Ambu aScope Duodeno, which is a sterile, single-use duodenoscope.

Hence, the growth in the occurrence of pancreatic cancer and a paradigm move toward minimally invasive procedures, and such factors are contributing to the growth of the endoscopic retrograde cholangiopancreatography industry.

Read More